Aqr Capital Management LLC Cara Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 13,998 shares of CARA stock, worth $5,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,998
Previous 33,005 57.59%
Holding current value
$5,319
Previous $8,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.26 - $0.38 $4,941 - $7,222
-19,007 Reduced 57.59%
13,998 $4,000
Q2 2024

Aug 14, 2024
BUY
$0.24 - $0.92 $1,004 - $3,852
4,187 Added 14.53%
33,005 $8,000
Q1 2024

May 15, 2024
SELL
$0.52 - $1.05 $415,990 - $839,980
-799,981 Reduced 96.52%
28,818 $26,000
Q4 2023

Feb 14, 2024
BUY
$0.6 - $1.65 $109,146 - $300,153
181,911 Added 28.12%
828,799 $613,000
Q3 2023

Nov 14, 2023
BUY
$1.67 - $3.33 $1.08 Million - $2.15 Million
646,888 New
646,888 $1.09 Million
Q2 2022

Aug 15, 2022
SELL
$7.45 - $13.84 $189,870 - $352,726
-25,486 Reduced 59.33%
17,470 $160,000
Q1 2022

May 16, 2022
SELL
$9.94 - $12.65 $746,931 - $950,571
-75,144 Reduced 63.63%
42,956 $522,000
Q4 2021

Feb 14, 2022
BUY
$11.99 - $18.14 $1.08 Million - $1.63 Million
89,738 Added 316.4%
118,100 $1.44 Million
Q3 2021

Nov 15, 2021
SELL
$11.55 - $16.06 $209,320 - $291,055
-18,123 Reduced 38.99%
28,362 $438,000
Q2 2021

Aug 16, 2021
BUY
$12.38 - $29.19 $451,436 - $1.06 Million
36,465 Added 363.92%
46,485 $663,000
Q1 2021

May 17, 2021
BUY
$15.07 - $21.71 $151,001 - $217,534
10,020 New
10,020 $218,000
Q1 2020

May 15, 2020
SELL
$9.12 - $17.78 $128,190 - $249,915
-14,056 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$16.11 - $25.98 $12,404 - $20,004
-770 Reduced 5.19%
14,056 $226,000
Q3 2019

Nov 14, 2019
BUY
$18.28 - $26.91 $74,600 - $109,819
4,081 Added 37.98%
14,826 $271,000
Q2 2019

Aug 14, 2019
BUY
$17.68 - $21.57 $189,971 - $231,769
10,745 New
10,745 $231,000
Q1 2019

May 14, 2019
SELL
$14.41 - $19.64 $151,895 - $207,025
-10,541 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$12.45 - $23.47 $131,235 - $247,397
10,541 New
10,541 $137,000
Q2 2018

Aug 14, 2018
SELL
$11.6 - $19.27 $195,077 - $324,063
-16,817 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$11.77 - $16.08 $170,523 - $232,967
-14,488 Reduced 46.28%
16,817 $208,000
Q4 2017

Feb 14, 2018
SELL
$11.86 - $14.08 $145,462 - $172,691
-12,265 Reduced 28.15%
31,305 $383,000
Q3 2017

Nov 14, 2017
BUY
$12.6 - $16.34 $548,982 - $711,933
43,570
43,570 $596,000

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $20.4M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email